Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values | 
| Product containing betamethasone and salicylic acid (medicinal product) | Is a | betametason för lokalt bruk | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | Betamethasone | true | Inferred relationship | Some | 1 | |
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | Adrenal hormone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | Corticosterone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | binjurehormonmedel | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Is a | Product containing salicylic acid (medicinal product) | true | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | keratolytiskt medel | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | Salicylic acid (substance) | true | Inferred relationship | Some | 2 | |
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | Glucocorticoid hormone | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has active ingredient | lokal produkt eller lokalt medel | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Has manufactured dose form | kutan och/eller transdermal läkemedelsform | false | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Is a | Product containing betamethasone (medicinal product) | true | Inferred relationship | Some | ||
| Product containing betamethasone and salicylic acid (medicinal product) | Plays role | Antifungal therapeutic role (role) | true | Inferred relationship | Some | 
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Betamethasone (as betamethasone dipropionate) 500 microgram/g and salicylic acid 30 mg/g cutaneous ointment | Is a | False | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| betametason 0,05 % + salicylsyra 3 %, för applicering i hårbottnen | Is a | False | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| Product containing betamethasone and salicylic acid in cutaneous dose form (medicinal product form) | Is a | True | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | |
| Betamethasone and salicylic acid only product | Is a | True | Product containing betamethasone and salicylic acid (medicinal product) | Inferred relationship | Some | 
This concept is not in any reference sets